KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
4.0100
-0.0900 (-2.20%)
As of 3:14PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close4.1000
Open4.1500
Bid4.0100 x 0
Ask4.0200 x 0
Day's Range3.8200 - 4.2600
52 Week Range0.8700 - 4.3500
Volume2,419,921
Avg. Volume1,495,333
Market Cap360.317M
Beta (3Y Monthly)3.23
PE Ratio (TTM)N/A
EPS (TTM)-0.4010
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.50
  • CNW Group5 days ago

    Why Analysts are Projecting $75 Billion Cannabis Market by 2030

    PALM BEACH, Florida , March 14, 2019 /CNW/ -- Recently, retail and online cannabis has had good news and bad news. The good news is that sales numbers continue to increase and projected revenues keep trending ...

  • Dixie Brands and Khiron Life Sciences to bring more than 100 market-proven products to the Latin American cannabis market
    CNW Group6 days ago

    Dixie Brands and Khiron Life Sciences to bring more than 100 market-proven products to the Latin American cannabis market

    DENVER and TORONTO, March 14, 2019 /CNW/ - Dixie Brands Inc. ("Dixie") (CSE:DIXI.U), (Frankfurt: 0QV), (OTC:DXBRF - News),  one of the cannabis industry's leading consumer packaged goods ("CPG") companies, and Khiron Life Sciences Corp. ("Khiron") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, have signed a definitive agreement (the "Agreement") relating to the joint venture (the "JV") the companies announced on January 30, 2019. With the execution of the Agreement, a new company called Dixie Khiron JV Corp. ("Dixie-Khiron") has been established, 50% owned by each of Dixie and Khiron.

  • CNW Group6 days ago

    Khiron Life Sciences Expands Skincare Leadership Team With The Appointment Of Dr. Edwin Bendek as Medical Director, Skincare

    Appointment further strengthens commercial skincare business where Company was first to launch products into Colombia market in 2018 Skincare unit targets $10 Billion Latin America skincare market Dr. ...

  • CNW Group7 days ago

    Khiron Life Sciences President Chris Naprawa To Present at 2019 LD Micro Virtual Conference

    TORONTO, March 12, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will be presenting at the second annual LD Micro Virtual Conference on March 13th at 12:20pm EDT. Khiron president Chris Naprawa will present and answer questions from participating investors.

  • ACCESSWIRE7 days ago

    LD Micro Virtual Conference Is Live, March 12th and 13th

    LOS ANGELES, CA / ACCESSWIRE / March 12 , 2019 / LD Micro, a company that puts on conferences for micro-cap and small-cap companies will be hosting 46 companies on March 12th (that's today) and 13th, starting ...

  • GlobeNewswire7 days ago

    THC to CBD: More Cannabis Companies Expand Their CBD Capabilities

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing number of cannabis companies expanding their CBD capabilities, following the major market trends for 2019. Every company and investor in the cannabis industry is well aware of the hype surrounding the potential for CBD and hemp. The momentum of CBD is making everyone take notice and many cannabis companies are not wasting this momentum for CBD, investing in new partnerships and business changes to ensure a strong position for the future.

  • GlobeNewswire11 days ago

    CBD Products Coming to a Store near You; CBD Companies Expand Reach

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the flurry of new distribution and marketing deals within the CBD sector, opening up product availability to a growing consumer base. Making headlines at the beginning of the month, cannabis leader, Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and Sequential Brands Group, Inc. announced that Martha Stewart joined the Company in an advisory role to assist with developing and positioning a broad new line of product offerings across multiple categories. “As soon as you hear the name Martha, you know exactly who we’re talking about,” shared Canopy Growth Chairman and co-CEO, Bruce Linton.

  • CNW Group14 days ago

    Khiron Introduces Kuida®, First Colombian CBD Cosmeceutical brand At Cosmoprof Worldwide Bologna, Targeting 200,000 Potential Global Retail Buyers

    TORONTO, March 5, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will participate in Cosmoprof Worldwide Bologna, taking place March 14-17 in Bologna, Italy. Recognized as the largest and most important event in the beauty buyers' calendar, this event brings the Company's Kuida® cosmeceutical portfolio to a global network of retail buyers and distributors.

  • CNW Group14 days ago

    Cannabis Companies Continue Their Growth With New Institutional Backing

    NEW YORK, March 5, 2019 /CNW/ -- The cannabis industry has recently been finding backers in major global investment banking firms such as Piper Jaffray, RBC Capital Markets, and Cowen. Piper Jaffray analyst Michael Lavery noted that there are more than 25 countries that have legalized marijuana of some form. According to data compiled by MarketsandMarkets, the global cannabis market is projected to grow from USD 10.3 Billion in 2018 to USD 39.4 Billion by 2023.

  • CNW Group15 days ago

    MEDIA ADVISORY: Khiron Life Sciences and CentroFox Host Cannamexico World Summit Toronto Reception and Q&A With Former Mexican President Vicente Fox

    TORONTO, March 4, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that the Company will host a Toronto reception on Thursday, March 7 to announce Cannamexico World Summit 2019, one of the largest and most influential cannabis conferences in Latin America. The Toronto reception will introduce the summit agenda, the first Canadian Pavilion and feature an exclusive on-stage Q&A with Mr. Vicente Fox, the 55th President of Mexico, and former CEO of Coca Cola Mexico.

  • Baystreet15 days ago

    The Top Cannabis Stocks with a Powerful Colombian Market Catalyst

    With favorable cannabis-growing conditions, Colombia is quickly emerging as an industry hot spot. In ...

  • CNW Group19 days ago

    Khiron Announces Closing of $28.84 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option

    TORONTO, Feb. 28, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF) is pleased to announce that it has closed today its previously announced  "bought deal" short form prospectus offering of common shares ("Common Shares"), including the exercise in full of the over-allotment option (the "Offering"). A total of 13,110,000 Common Shares were sold at a price of $2.20 per Common Share (the "Issue Price") for aggregate gross proceeds of $28,842,000 (including the exercise in full of the over-allotment option).

  • CNW Group19 days ago

    Cannabis Companies Pursuing Growth Set Sights on Latina America

    NEW YORK, Feb. 28, 2019 /CNW/ --The Latin America region has become highly sought after for cannabis businesses due to the opportunities it represents. Around the globe, many cannabis businesses have moved to establish operations in LATAM because of the area's low cultivation costs and fertile farming lands, as countries including Peru, Chile, Argentina, and Colombia have all passed favourable medical cannabis laws. Meanwhile, Uruguay has entirely legalized cannabis for both recreational and medical use.

  • CNW Group22 days ago

    Countries Following in Canada's Footsteps on Cannabis Legalization

    NEW YORK, Feb. 25, 2019 /CNW/ -- Following Canada's legalization of cannabis, the North American cannabis industry is positioned to account for the majority of the global marketplace. Canada legalized recreational cannabis nationwide in October, making it the first G-7 country to do so. Now, Mexico's President-elect party is moving to legalize cannabis as well.

  • ACCESSWIRE27 days ago

    Three of the Best Ways to Invest in Colombia's Fast-Growing Medical Marijuana Market

    HOUSTON, TX / ACCESSWIRE / February 20, 2019 / Colombia is on its way to becoming one of the largest global exporters of medical marijuana. "With a potential count more than double Canada's, Colombia's medical marijuana market is quickly gaining recognition as a legitimate force in the global cannabis industry," notes Marijuana Business Daily. In addition, at current pace, Colombia could supply 44% of the global demand for medical cannabis, according to Andres Lopez, director of Colombia's National Drug Fund, as quoted by Medical Marijuana Inc.

  • CNW Group28 days ago

    IIROC Trading Halt - KHRN

    VANCOUVER , Feb. 19, 2019 /CNW/ - The following issues have been halted by IIROC: Company: Khiron Life Sciences Corp. TSX-Venture Symbol: KHRN Reason: Single Stock Circuit Breaker Halt Time (ET): 10:13:39:436 ...

  • CNW Group28 days ago

    IIROC Trading Resumption - KHRN

    VANCOUVER , Feb. 19, 2019 /CNW/ - Trading resumes in: Company: Khiron Life Sciences Corp. TSX-Venture Symbol: KHRN Resumption (ET): 10:18:39 IIROC can make a decision to impose a temporary suspension (halt) ...

  • ACCESSWIRElast month

    Top 3 Cannabis Stocks Higher on Colombian Growth Story

    HOUSTON, TX / ACCESSWIRE / February 14, 2019 / Colombia is just beginning to transform itself into a multi-billion-dollar cannabis producer for the pharmaceutical industry. "Colombia is wooing foreign investors, talking up its potential in the new era of peace as a resource-rich country with a business-friendly regulatory environment," noted The Globe and Mail. Blueberries Medical Corp. (BBM), for example, just entered into a letter of intent for a joint venture with Harmony and Life S.A.S., operating as El Manantial medical centers.

  • GlobeNewswirelast month

    Branding Becomes Key as CBD is Expected to Overtake the Cannabis Market

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot reporting on the CBD market As it grows, branding becomes essential to companies hoping to stand out. According to Brightfield Group analysts, the CBD market is expected to hit $22 billion by 2022, overtaking the cannabis market with $20 billion by 2020. This is good news for most companies in the sector, but it also adds to market saturation, which means brand awareness may be the only way to stay ahead of the pack.

  • Do Institutions Own Khiron Life Sciences Corp. (CVE:KHRN) Shares?
    Simply Wall St.last month

    Do Institutions Own Khiron Life Sciences Corp. (CVE:KHRN) Shares?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! A look at the shareholders of KhironRead More...

  • CNW Grouplast month

    Khiron Life Sciences announces upsize of previously announced bought deal equity financing to $25 million

    VANCOUVER, Feb. 6, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. and BMO Capital Markets as co-lead underwriters and joint bookrunners, and including Cormark Securities Inc. (together, the "Underwriters"), to increase the size of its previously announced "bought deal" financing from $20,020,000 to $25,080,000 (the "Offering"). Pursuant to the amended terms, the Underwriters have agreed to purchase 11,400,000 common shares of the Company ("Common Shares"), on a "bought deal" basis pursuant to a short form prospectus offering, subject to all required regulatory approvals, at a price per Common Share of $2.20 (the "Issue Price").

  • CNW Grouplast month

    Khiron Life Sciences Enters Into $20 Million Bought Deal Equity Financing

    VANCOUVER, Feb. 6, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. and BMO Capital Markets as co-lead underwriters and joint bookrunners, and including Cormark Securities Inc. (together, the "Underwriters") under which the Underwriters have agreed to purchase 9,100,000 common shares of the Company ("Common Shares"), on a "bought deal" basis pursuant to a short form prospectus offering, subject to all required regulatory approvals, at a price per Common Share of $2.20 (the "Issue Price") for gross proceeds of $20,020,000 (the "Offering"). The Company has also granted the Underwriters an over-allotment option (the "Over-Allotment Option") to purchase up to an additional 15% of the Common Shares at the Issue Price, exercisable in whole or in part at any time on or up to 30 days following the closing of the Offering.

  • CNW Group2 months ago

    Reminder: Dixie Brands and Khiron Life Sciences to Host Investor Call

    DENVER and TORONTO , Jan. 31, 2019 /CNW/ - Dixie Brands Inc. (" Dixie ") (CSE: DIXI.U), (Frankfurt : 0QV), one of the cannabis industry's leading consumer packaged goods companies, and Khiron ...